Cargando…
Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
Enhancing the intracellular delivery and performance of RNA-guided CRISPR-Cas9 nucleases (RGNs) remains in demand. Here, we show that nuclear translocation of commonly used Streptococcus pyogenes Cas9 (SpCas9) proteins is suboptimal. Hence, we generated eCas9.4NLS by endowing the high-specificity eS...
Autores principales: | Maggio, Ignazio, Zittersteijn, Hidde A., Wang, Qian, Liu, Jin, Janssen, Josephine M., Ojeda, Ivan Toral, van der Maarel, Silvère M., Lankester, Arjan C., Hoeben, Rob C., Gonçalves, Manuel A. F. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253353/ https://www.ncbi.nlm.nih.gov/pubmed/31900423 http://dx.doi.org/10.1038/s41434-019-0119-y |
Ejemplares similares
-
Adenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells
por: Maggio, Ignazio, et al.
Publicado: (2016) -
A primer to gene therapy: Progress, prospects, and problems
por: Zittersteijn, Hidde A., et al.
Publicado: (2020) -
Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells
por: Maggio, Ignazio, et al.
Publicado: (2014) -
A Small Key for a Heavy Door: Genetic Therapies for the Treatment of Hemoglobinopathies
por: Zittersteijn, Hidde A., et al.
Publicado: (2021) -
Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
por: Voets, Olaf, et al.
Publicado: (2017)